Literature DB >> 498174

Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report.

D S Alberts, S Y Chang, H S Chen, B J Larcom, S E Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 498174     DOI： 10.1016/s0305-7372(79)80005-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  9 in total

Review 1.  Mass balance studies, with a focus on anticancer drugs.

Authors:  Jan H Beumer; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.

Authors:  P Hartvig; B Simonsson; G Oberg; I Wallin; H Ehrsson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards.

Authors:  D Godenèche; J C Madelmont; M F Moreau; R Plagne; G Meyniel
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

5.  Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard.

Authors:  H Ehrsson; I Wallin; B Simonsson; P Hartvig; G Oberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

7.  In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs.

Authors:  Michael J Reese; Deborah W Knapp; Kimberly M Anderson; Julie A Mund; Jamie Case; David R Jones; Rebecca A Packer
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

8.  Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism.

Authors:  Rida Mourtada; Sonali B Fonseca; Simon P Wisnovsky; Mark P Pereira; Xiaoming Wang; Rose Hurren; Jeremy Parfitt; Lesley Larsen; Robin A J Smith; Michael P Murphy; Aaron D Schimmer; Shana O Kelley
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

9.  In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

Authors:  A P Wilson; F E Neal
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.